Qnovia Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$14.2M
- Investors
-
10
Qnovia General Information
Description
Developer of a drug delivery platform designed to advance pharmaceutical research and treatments aimed at saving lives. The company's platform offers an inhalation-based technology that addresses many of the limitations of traditional pharmaceutical drug delivery systems to improve patient outcomes that optimize human factors and tackle critical medical challenges, enabling patients to get a variety of new inhaled therapies and improve health.
Contact Information
Website
www.qnovia.comCorporate Office
- 2920 West Broad Street
- Suite 243
- Richmond, VA 23230
- United States
Corporate Office
- 2920 West Broad Street
- Suite 243
- Richmond, VA 23230
- United States
Qnovia Timeline
Qnovia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 10-Dec-2024 | $14.2M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series A) | 07-Jun-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 13-Jan-2020 | $2.25M | $2.25M | Completed | Generating Revenue |
Qnovia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-6 | ||||||||
| A-5 Preferred | ||||||||
| A-4 Preferred | ||||||||
| A-3 Preferred | ||||||||
| A-2 Preferred | 419,251 | $0.000100 | $16.42 | $16.42 | 1x | $16.42 | 3.24% | |
| A-1 Preferred | 1,053,741 | $0.000100 | $19.32 | $19.32 | 1x | $19.32 | 8.14% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Qnovia Comparisons
Industry
Financing
Details
Qnovia Competitors (5)
One of Qnovia’s 5 competitors is Respira Therapeutics, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Respira Therapeutics | Venture Capital-Backed | Palo Alto, CA | ||||
| Cala Health | Venture Capital-Backed | San Mateo, CA | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Cycle Pharmaceuticals | Corporation | Cambridge, United Kingdom | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA |
Qnovia Patents
Qnovia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4510873-A1 | Electronic devices for aerosolizing and inhaling liquid | Pending | 22-Apr-2022 | ||
| EP-4510873-A4 | Electronic devices for aerosolizing and inhaling liquid | Pending | 22-Apr-2022 | ||
| US-20230337735-A1 | Electronic devices for aerosolizing and inhaling liquid | Active | 22-Apr-2022 | ||
| US-20230389605-A1 | Electronic devices for aerosolizing and inhaling liquid | Active | 22-Apr-2022 | ||
| US-20240407432-A1 | Electronic devices for aerosolizing and inhaling liquid | Active | 22-Apr-2022 | A24F40/485 |
Qnovia Signals
Qnovia Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Timeless Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Third Lake Capital | Family Office | Minority | ||
| Vice Ventures | Venture Capital | Minority | ||
| Blue Ledge Capital | Venture Capital | Minority |
Qnovia FAQs
-
When was Qnovia founded?
Qnovia was founded in 2018.
-
Where is Qnovia headquartered?
Qnovia is headquartered in Richmond, VA.
-
What is the size of Qnovia?
Qnovia has 8 total employees.
-
What industry is Qnovia in?
Qnovia’s primary industry is Therapeutic Devices.
-
Is Qnovia a private or public company?
Qnovia is a Private company.
-
What is the current valuation of Qnovia?
The current valuation of Qnovia is .
-
What is Qnovia’s current revenue?
The current revenue for Qnovia is .
-
How much funding has Qnovia raised over time?
Qnovia has raised $43.5M.
-
Who are Qnovia’s investors?
Timeless Ventures, Gaingels, Third Lake Capital, Vice Ventures, and Blue Ledge Capital are 5 of 10 investors who have invested in Qnovia.
-
Who are Qnovia’s competitors?
Respira Therapeutics, Cala Health, Verge Labs, Cycle Pharmaceuticals, and Sarepta Therapeutics are competitors of Qnovia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process